BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 30393942)

  • 1. Minimizing radiographic contrast administration during coronary angiography using a novel contrast reduction system: A multicenter observational study of the DyeVert™ plus contrast reduction system.
    Gurm HS; Mavromatis K; Bertolet B; Kereiakes DJ; Amin AP; Shah AP; Hanzel GS; Rao S; Thomas JL; Kumar G
    Catheter Cardiovasc Interv; 2019 Jun; 93(7):1228-1235. PubMed ID: 30393942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography.
    Mehran R; Faggioni M; Chandrasekhar J; Angiolillo DJ; Bertolet B; Jobe RL; Al-Joundi B; Brar S; Dangas G; Batchelor W; Prasad A; Gurm HS; Tumlin J; Stone GW
    JACC Cardiovasc Interv; 2018 Aug; 11(16):1601-1610. PubMed ID: 30139467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Feasibility Study of the DyeVert™ Plus Contrast Reduction System to Reduce Contrast Media Volumes in Percutaneous Coronary Procedures Using Optical Coherence Tomography.
    Zimin VN; Jones MR; Richmond Iv T; Durieux JC; Alaiti AM; Pereira GTR; Vergara-Martel A; Pizzato PE; Zago EI; Dallan LA; Bezerra HG
    Cardiovasc Revasc Med; 2021 Sep; 30():40-46. PubMed ID: 33046416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A first in human evaluation of a novel contrast media saving device.
    Sapontis J; Barron G; Seneviratne S; Fuernau G; Eitel I; Ledwoch J; Thiele H; Saad M; de Waha S; Poess J; Desch S
    Catheter Cardiovasc Interv; 2017 Nov; 90(6):928-934. PubMed ID: 28471046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a novel contrast reduction system on contrast savings in coronary angiography - The DyeVert randomised controlled trial.
    Desch S; Fuernau G; Pöss J; Meyer-Saraei R; Saad M; Eitel I; Thiele H; de Waha S
    Int J Cardiol; 2018 Apr; 257():50-53. PubMed ID: 29373136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra-Low Contrast Percutaneous Coronary Intervention to Minimize the Risk for Contrast-Induced Acute Kidney Injury in Patients With Severe Chronic Kidney Disease.
    Azzalini L; Laricchia A; Regazzoli D; Mitomo S; Hachinohe D; Bellini B; Demir OM; Poletti E; Maccagni D; Colombo A
    J Invasive Cardiol; 2019 Jun; 31(6):176-182. PubMed ID: 30865912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast media volume reduction with the DyeVert
    Paolucci L; De Micco F; Bezzeccheri A; Scarpelli M; Esposito G; Airoldi F; Focaccio A; Briguori C
    Catheter Cardiovasc Interv; 2023 Oct; 102(4):655-662. PubMed ID: 37668067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.
    Shehata M; Hamza M
    Cardiovasc Ther; 2015 Apr; 33(2):35-41. PubMed ID: 25677920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of urinary liver-type fatty acid-binding protein as predicting factor for occurrence of contrast-induced acute kidney injury and its reduction by hemodiafiltration with blood suction from right atrium.
    Katoh H; Nozue T; Kimura Y; Nakata S; Iwaki T; Kawano M; Kawashiri MA; Michishita I; Yamagishi M
    Heart Vessels; 2014 Mar; 29(2):191-7. PubMed ID: 23604313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention: A Subgroup Analysis of the PRESERVE Trial.
    Garcia S; Bhatt DL; Gallagher M; Jneid H; Kaufman J; Palevsky PM; Wu H; Weisbord SD;
    JACC Cardiovasc Interv; 2018 Nov; 11(22):2254-2261. PubMed ID: 30466822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-low-contrast angiography in patients with advanced chronic kidney disease and previous coronary artery bypass surgery.
    Rahim HM; Flattery E; Gkargkoulas F; Maehara A; Mintz GS; Hardy MA; Cohen DJ; Dube GK; Crew RJ; Mohan S; Radhakrishnan J; Ratner LE; Moses JW; Ben-Yehuda O; Kirtane AJ; Stone GW; Leon MB; Karmpaliotis D; Ali ZA
    Coron Artery Dis; 2019 Aug; 30(5):346-351. PubMed ID: 31094895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DyeVert Contrast Reduction System Use in Patients Undergoing Coronary and/or Peripheral Angiography: A Systematic Literature Review and Meta-Analysis.
    Tarantini G; Prasad A; Rathore S; Bansal S; Gottfried R; Rosenkranz AR; Briguori C; Yaghoubi M; Mashayekhi A; Javanbakht M; Moloney E
    Front Med (Lausanne); 2022; 9():841876. PubMed ID: 35547222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prediction model of contrast-associated acute kidney injury in patients with hypoalbuminemia undergoing coronary angiography.
    Liu L; Liu J; Lei L; Wang B; Sun G; Guo Z; He Y; Song F; Lun Z; Liu B; Chen G; Chen S; Yang Y; Liu Y; Chen J
    BMC Cardiovasc Disord; 2020 Aug; 20(1):399. PubMed ID: 32867690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a contrast media volume control device on acute kidney injury rate in patients with acute coronary syndrome.
    Briguori C; Golino M; Porchetta N; Scarpelli M; De Micco F; Rubino C; Focaccio A; Signoriello G
    Catheter Cardiovasc Interv; 2021 Jul; 98(1):76-84. PubMed ID: 32682348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
    Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and Incidence of Contrast-Induced Acute Kidney Injury Following Coronary Angiography - Five Year Experience at a Tertiary Care Center.
    Sreenivasan J; Khan MS; Li H; Zhuo M; Patel A; Fugar S; Tarbutton M; Siddamsetti S; Yadav N
    Cardiovasc Revasc Med; 2019 Aug; 20(8):654-658. PubMed ID: 30318173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-procedural renal resistive index accurately predicts contrast-induced acute kidney injury in patients with preserved renal function submitted to coronary angiography.
    Wybraniec MT; Bożentowicz-Wikarek M; Chudek J; Mizia-Stec K
    Int J Cardiovasc Imaging; 2017 May; 33(5):595-604. PubMed ID: 27995343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute kidney injury following coronary angiography: a nationwide study of incidence, risk factors and long-term outcomes.
    Helgason D; Long TE; Helgadottir S; Palsson R; Sigurdsson GH; Gudbjartsson T; Indridason OS; Gudmundsdottir IJ; Sigurdsson MI
    J Nephrol; 2018 Oct; 31(5):721-730. PubMed ID: 30187381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
    Kim JH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC
    Am J Cardiol; 2014 Dec; 114(12):1830-5. PubMed ID: 25438909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.
    Akrawinthawong K; Ricci J; Cannon L; Dixon S; Kupfer K; Stivers D; Alexander P; David S; McCullough PA
    Ren Fail; 2015 Mar; 37(2):187-91. PubMed ID: 25519207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.